Open Access iconOpen Access

ARTICLE

Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathways

TIANZHU LI1,#, YU ZHANG2,#, TONG ZHANG2,#, YANNAN LI2, HUI XUE2, JINGLONG CAO2, WENSHUANG HOU2, YINGHUA LUO3,*, CHENGHAO JIN2,4,*,

1 Department of Molecular Biology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China
2 Department of Biochemistry and Molecular Biology, College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, China
3 Department of Grass Science, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, China
4 National Coarse Cereals Engineering Research Center, Daqing, 163319, China

* Corresponding Authors: Yinghua Luo, email; Chenghao Jin, email
# These authors contributed equally to this work

(This article belongs to the Special Issue: Herbal Active Ingredients: Potential for the Prevention and Treatment of Cancer)

BIOCELL 2023, 47(1), 195-204. https://doi.org/10.32604/biocell.2023.025593

Abstract

Schisandrin B (Sch B) is a monomer with anti-cancer and anti-inflammatory effects, which are isolated from the plant Schisandra chinensis (Turcz) Baillon. We investigated the anti-gastric cancer (GC) effects of Sch B and its underlying molecular mechanisms. The Cell Counting Kit-8 assay was used to determine the effects of Sch B on the viability of GC and normal cell lines. Hoechst/propidium iodide staining and flow cytometry were used to assess the apoptosis induction of Sch B. Western blotting was used to evaluate the effects of Sch B on downstream apoptotic proteins. The DCFH-DA fluorescent probe was used to assess the regulatory effects of Sch B on reactive oxygen species (ROS) levels and related signaling pathways in GC cells. The results showed that Sch B could regulate the phosphorylation level of mitogen-activated protein kinase (MAPK) by upregulating ROS accumulation in gastric cancer cells, and then reduce the expression of nuclear factor kappa B (NF-κB) and phosphorylated transcription 3 (p-STAT3). In addition, Sch B downregulated the cell cycle proteins cyclin-dependent kinase 2/4/6 and cyclin D1/E, and arrested cells in the G0/G1 phase. Moreover, it also inhibited cell migration, which was reversed with Nacetylcysteine pretreatment. In summary, Sch B has killing effects on GC cells by upregulating the production of intracellular ROS and regulating the MAPK/STAT3/NF-κB signaling pathway, leading to the migration arrest and apoptosis of GC cells.

Keywords


Cite This Article

APA Style
LI, T., ZHANG, Y., ZHANG, T., LI, Y., XUE, H. et al. (2023). Schisandrin B exerts anticancer effects on human gastric cancer cells through ros-mediated MAPK, STAT3, and NF-κB pathways. BIOCELL, 47(1), 195-204. https://doi.org/10.32604/biocell.2023.025593
Vancouver Style
LI T, ZHANG Y, ZHANG T, LI Y, XUE H, CAO J, et al. Schisandrin B exerts anticancer effects on human gastric cancer cells through ros-mediated MAPK, STAT3, and NF-κB pathways. BIOCELL . 2023;47(1):195-204 https://doi.org/10.32604/biocell.2023.025593
IEEE Style
T. LI et al., "Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathways," BIOCELL , vol. 47, no. 1, pp. 195-204. 2023. https://doi.org/10.32604/biocell.2023.025593



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1766

    View

  • 669

    Download

  • 0

    Like

Share Link